(Q57223375)

2

0 references

Y H Chan

3

0 references

J Griffith

4

0 references

E.M.C Lau

1

0 references

Y.H Chan

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

3

0 references

language of work or name

English

0 references

publication date

November 2000

0 references

published in

Bone

0 references

volume

27

0 references

issue

5

0 references

page(s)

677-80

0 references

677-680

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900378-1

7 January 2021

Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900378-1

7 January 2021

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900378-1

7 January 2021

A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900378-1

7 January 2021

Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900378-1

7 January 2021

Prevalent vertebral deformities: relationship to bone mineral density and spinal osteophytosis in elderly men and women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900378-1

7 January 2021

Normal ranges for vertebral height ratios and prevalence of vertebral fracture in Hong Kong Chinese: a comparison with American Caucasians

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900378-1

7 January 2021

Physical activity and calcium intake in fracture of the proximal femur in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900378-1

7 January 2021

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900378-1

7 January 2021

Perspective. How many women have osteoporosis?

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900378-1

7 January 2021

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900378-1

7 January 2021

Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2800%2900378-1

7 January 2021